Improved PCR-based subtractive hybridization strategy for cloning differentially expressed genes

Area of Science:

• Molecular Biology
• Cancer Research
• Genetics

Background:

• Apoptosis, or programmed cell death, is crucial in cellular regulation and disease.
• Identifying genes involved in apoptosis is key to understanding and treating diseases like promyelocytic leukemia.
• All-trans retinoic acid (ATRA) is a known therapeutic agent that can induce apoptosis in certain cancer cells.

Purpose of the Study:

• To develop and optimize a PCR-based subtractive hybridization strategy for cloning apoptosis-related genes.
• To identify novel genes induced by all-trans retinoic acid (ATRA) in the human promyelocytic leukemia cell line HL-60.
• To assess the efficiency of the developed strategy for large-scale gene cloning.

Main Methods:

• Utilized an improved PCR-based subtractive hybridization strategy.
• Employed the cap-finder method, long-distance PCR, streptavidin magnetic bead-mediated subtraction, and spin column chromatography.
• Identified apoptosis-related clones using reverse dot blot assay.

Main Results:

• Identified 27 apoptosis-related clones.
• Confirmed 7 known apoptosis-related genes and 10 unknown genes.
• Sequenced five novel genes (apr-1 to apr-5) and suggested their potential role in apoptosis, along with TNF and apr-1, apr-2, apr-3.

Conclusions:

• The developed PCR-based subtractive hybridization strategy is efficient for cloning differentially expressed genes.
• This method facilitates the identification of novel apoptosis-related genes.
• The findings contribute to understanding ATRA-induced apoptosis in HL-60 cells and offer a tool for broader gene discovery.